OncoResponse Appoints Sean McCarthy to Board of Directors
07 juil. 2021 07h00 HE
|
OncoResponse, Inc.
SEATTLE, July 07, 2021 (GLOBE NEWSWIRE) -- OncoResponse, a biotechnology company harnessing the power of the human immune system to identify and develop novel monoclonal antibodies to...
OncoResponse Appoints Chris Russell as Chief Financial Officer
11 mai 2021 07h00 HE
|
OncoResponse, Inc.
SEATTLE, May 11, 2021 (GLOBE NEWSWIRE) -- OncoResponse, a biotechnology company harnessing the power of the human immune system to identify and develop novel monoclonal antibodies to...
OncoResponse Raises $40.6 Million Series C Financing
31 mars 2021 07h00 HE
|
OncoResponse, Inc.
- New capital will fund lead antibody, OR2805, through Phase 1 and 2 clinical studies - Adds Magnetar Group, Yonjin Ventures and Bering Capital to the syndicate SEATTLE, March 31, 2021 (GLOBE...